title: Breast Hypertrophy Induced by Ombitasvir/Paritaprevir/Ritonavir and Ribavirina.
authors.affiliation: Unit of Clinical Pharmacology, Department of Biomedical and Clinical Sciences, "Luigi Sacco" University Hospital, Università di Milano, Milan, Italy.
authors.forename: Marta
authors.initials: M
authors.lastname: Gentili
authors.affiliation: Units of Infectious Diseases, "Luigi Sacco" University Hospital, Università di Milano, Milan, Italy.
authors.forename: Carlo
authors.initials: C
authors.lastname: Magni
authors.affiliation: Unit of Clinical Pharmacology, Department of Biomedical and Clinical Sciences, "Luigi Sacco" University Hospital, Università di Milano, Milan, Italy.
authors.forename: Carla
authors.initials: C
authors.lastname: Carnovale
authors.affiliation: Units of Infectious Diseases, "Luigi Sacco" University Hospital, Università di Milano, Milan, Italy.
authors.forename: Matteo
authors.initials: M
authors.lastname: Bolis
authors.affiliation: Units of Infectious Diseases, "Luigi Sacco" University Hospital, Università di Milano, Milan, Italy.
authors.forename: Simona
authors.initials: S
authors.lastname: Landonio
authors.affiliation: Units of Infectious Diseases, "Luigi Sacco" University Hospital, Università di Milano, Milan, Italy.
authors.forename: Fosca
authors.initials: F
authors.lastname: Niero
authors.affiliation: Unit of Clinical Pharmacology, Department of Biomedical and Clinical Sciences, "Luigi Sacco" University Hospital, Università di Milano, Milan, Italy.|Scientific Direction, IRCCS Foundation Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
authors.forename: Stefania
authors.initials: S
authors.lastname: Antoniazzi
authors.affiliation: Scientific Institute, IRCCS E. Medea, Lecco, Italy.|Unit of Clinical Pharmacology, Department of Biomedical and Clinical Sciences, Consiglio Nazionale delle Ricerche, Institute of Neuroscience, University Hospital "Luigi Sacco", Università di Milano, Milan, Italy.
authors.forename: Emilio
authors.initials: E
authors.lastname: Clementi
authors.affiliation: Unit of Clinical Pharmacology, Department of Biomedical and Clinical Sciences, "Luigi Sacco" University Hospital, Università di Milano, Milan, Italy.
authors.forename: Sonia
authors.initials: S
authors.lastname: Radice
mesh_terms: D000813:Anilides / Q000009:adverse effects / Q000627:therapeutic use; D000998:Antiviral Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001941:Breast Diseases / Q000139:chemically induced*; D002219:Carbamates / Q000009:adverse effects / Q000627:therapeutic use; D003521:Cyclopropanes; D004359:Drug Therapy, Combination / Q000009:adverse effects; D005260:Female; D006526:Hepatitis C / Q000188:drug therapy; D006801:Humans; D006984:Hypertrophy / Q000139:chemically induced; D047029:Lactams, Macrocyclic; D047028:Macrocyclic Compounds / Q000009:adverse effects / Q000627:therapeutic use; D008875:Middle Aged; D011392:Proline / Q000031:analogs & derivatives; D012254:Ribavirin / Q000009:adverse effects / Q000627:therapeutic use; D019438:Ritonavir / Q000009:adverse effects / Q000627:therapeutic use; D013449:Sulfonamides; D014633:Valine
chemical_list: D000813:Anilides; D000998:Antiviral Agents; D002219:Carbamates; D003521:Cyclopropanes; D047029:Lactams, Macrocyclic; D047028:Macrocyclic Compounds; D013449:Sulfonamides; C586094:ombitasvir; D012254:Ribavirin; D011392:Proline; D014633:Valine; D019438:Ritonavir; C585405:paritaprevir